head-and-neck-cancer

Documents about head-and-neck-cancer

• Longitudinal correlates of psychological resilience during particle radiotherapy among patients with head and neck cancer: A cross-lagged panel network analysis.#10004PubMed
• Multimodal identification of a rare head and neck cancer patient cohort in the clinical data warehouse of Greater Paris Teaching Hospital#364037HAL (France)
• INTEGRATION OF ARTIFICIAL INTELLIGENCE IN QUALITY ASSURANCE FOR HEAD AND NECK CANCER RADIOTHERAPY CLINICAL TRIALS#929154ScholarlyCommons
• Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas#1031226ClinicalTrials.gov
• Study of XB010 in Subjects With Solid Tumors#898289ClinicalTrials.gov
• Safety, Tolerability, and Preliminary Antitumor Activity of Non-Cationic Peptide-CD47 siRNA in Advanced Solid Tumors#905941ClinicalTrials.gov
• A Phase 1 of CTX-8371 in Patients With Advanced Malignancies#804246ClinicalTrials.gov
• Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation#842870ClinicalTrials.gov
• First in Human Study of TUB-030 in Patients With Advanced Solid Tumors#884376ClinicalTrials.gov
• A Quantitative Comparison between Shannon and Tsallis–Havrda–Charvat Entropies Applied to Cancer Outcome Prediction#308340HAL (France)
• A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors#467592ClinicalTrials.gov
• Evaluating Effectiveness of mHealth Interventions for Rehabilitation in Patients With Head and Neck Cancer: Systematic Review and Meta-Analysis of Randomized Controlled Trials.#148104NCBI PubMed Central
• Th17-mediated antitumor immunity in patient-derived organoid and autologous immune cell cocultures predicts response to immunotherapy in head and neck cancer.#281003NCBI PubMed Central
• Quantifying Systemic Immunosuppression to Personalize Cancer Therapy#851374ClinicalTrials.gov
• Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer#880923ClinicalTrials.gov
• Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors#894403ClinicalTrials.gov
• A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma#394772ClinicalTrials.gov
• Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies#885479ClinicalTrials.gov
• Study of ADCT-301 in Patients With Selected Advanced Solid Tumors#814039ClinicalTrials.gov
• 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors#881267ClinicalTrials.gov
• Timing for Radiotherapy Initiation After Dental Extraction and Risk of Osteoradionecrosis in Head and Neck Cancer Patients: A Systematic Review and Meta-Analysis.#402630NCBI PubMed Central
• A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies#287543ClinicalTrials.gov
• Phase I Study of the Combination of Afatinib and Ruxolitinib in Patients With Treatment-refractory Non-Small Cell Lung Cancer (NSCLC)#873250ClinicalTrials.gov
• Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in Mexico#1044447ClinicalTrials.gov
• Oral HPV Infection in Young Men#907015ClinicalTrials.gov
• A Study of DB-1310 in Advanced/Metastatic Solid Tumors#918291ClinicalTrials.gov
• Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors#833985ClinicalTrials.gov
• Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors#802745ClinicalTrials.gov
• Towards Cure Via Only Ultra-short ICB in CSCC#152388ClinicalTrials.gov
• “Life after treatment”: what physicians consider important for oral cancer survivors’ quality of life#186677ULRR
• SPIO-enhanced MRI in Oral Cancer for Sentinel Lymph Node Identification#836962ClinicalTrials.gov
• Effectiveness of Photobiomodulation Protocols in Radiation-induced Oral Side Effects in H&N Cancer Patients#1031741ClinicalTrials.gov
• Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer#854755ClinicalTrials.gov
• Study of Nivolumab Alone or in Combination With Ipilimumab as Immunotherapy vs Standard Follow-up in Surgical Resectable HNSCC After Adjuvant Therapy#174869ClinicalTrials.gov
• SHAP-based interpretable machine learning with longitudinal delta-radiomics across seven weeks of treatment for xerostomia prediction in head-and-neck cancer.#239725NCBI PubMed Central
• Surgica; Management of Skin Cancers of the Head and Neck#368442OpenUCT
• Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab#369832ClinicalTrials.gov
• De-Escalation Postoperative Radiotherapy for Oral Squamous Cell Carcinoma With pCR/MPR.#651256ClinicalTrials.gov
• The Effects of Whole Food Intervention on Mucositis in Patients Treated for Head and Neck Cancer#831850ClinicalTrials.gov
• The Use of Integra in Coverage of Radial Forearm Free Flap Donor Site Defect#837219ClinicalTrials.gov
• Verification of Saliva MMP-1 as a Diagnostic Marker of Oral Cavity Cancer#982574ClinicalTrials.gov
• Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitors#460978HAL (France)
• The Efficacy of Induction and Adjuvant Camrelizumab Combined With Chemoradiation for LA-HNSCC#804516ClinicalTrials.gov
• Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer#859942ClinicalTrials.gov
• Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer#1033128ClinicalTrials.gov
• Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors#879788ClinicalTrials.gov
• S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer#857416ClinicalTrials.gov
• Innovative screening for OSAS in patients with head and neck cancer using the apneal application: Protocol for a prospective single-centre study#305605PLOS
• Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer#876718ClinicalTrials.gov
• Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours#854029ClinicalTrials.gov